Risks of latex avoidance.
Spickett
G P
GP
Regional Department of ImmunologyRoyal Victoria InfirmaryNewcastle upon Tyne NE1 4LPUKTel. +44-91-2824281Fax: +44-91-2275071E-mail: gavin.spickett@nuth.northy.nhs.uk
Wright
L J
LJ
D000328:Adult; D000918:Antibody Specificity / Q000276:immunology; D000937:Antigen-Antibody Reactions / Q000276:immunology; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology*; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology; D007840:Latex / Q000009:adverse effects*; D020315:Latex Hypersensitivity / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology*; D012307:Risk Factors; D012882:Skin Tests; D014481:United States / Q000453:epidemiology
D007840:Latex; D007073:Immunoglobulin E